Home » Health » Dexamethasone-this study is according to the WHO breakthrough in the fight against Covid-19 – TOP ONLINE

Dexamethasone-this study is according to the WHO breakthrough in the fight against Covid-19 – TOP ONLINE

It was a “life-saving scientific breakthrough,” said WHO chief Tedros Adhanom Ghebreyesus in the night to Wednesday in Geneva.

Dexamethasone, the first form of treatment, the death rate of respiration machines connected Covid-19-sink patients undetectable was. Tedros spoke of great news and congratulated the British government.

Study by the University of Oxford

Researchers led by a team at the University of Oxford had administered for the government-financed study, the widely available drug for ten days, more than 2000 with the Coronavirus-infected patients.

Accordingly, dexamethasone reduced the mortality rate of the ventilator-dependent patient is 35 percent. For patients with only oxygen were administered, reduced the mortality rate by a fifth.

In patients with a milder disease course of dexamethasone, however, showed no effect. As a control, the researchers studied 4000 patients that were not treated with dexamethasone. Detailed Reviews of the clinical trial have not been published yet.

Remedies for allergies

Dexamethasone is included in a variety of anti-inflammatory drugs. It is used to treat allergic reactions, rheumatoid Arthritis and Asthma. According to British researchers, the daily doses could prevent every eighth death in critically ill Covid patients.

The scientists celebrated the discovery as a major breakthrough in the fight against the novel Coronavirus, the disease brought. They emphasised that dexamethasone is readily available and inexpensive. The British government put the funds immediately to the list of standard procedures of the National health service NHS counter-Covid-19.

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.